Groowe Groowe / Newsroom / TEVA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TEVA News

Teva Pharmaceutical Industries Limited American Depositary Shares

The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults

globenewswire.com
TEVA

Interact Advances its Agentic AI Vision with Content Moderation, Cross-System Search, and Workday Workflows

globenewswire.com
DPZ TEVA

Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer

globenewswire.com
TEVA GILD ABBV PFE

Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

globenewswire.com
TEVA

Carella Byrne Cecchi Brody Agnello, P.C. Announce a Class Action Settlement If You Paid for, Purchased, or Provided Reimbursement For a Drug Which Contained Metformin From July 20, 2015 through June 2, 2020

prnewswire.com
TEVA

Fenebrutinib Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

globenewswire.com
TEVA

Albuterol Sulfate Metered Dose Inhalers Market Analysis Report 2026: $7.61 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
AMPH TEVA

Teva to Present at the BofA Securities Health Care Conference

globenewswire.com
TEVA

Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight

globenewswire.com
VNDA GRFS BHC RDHL MRK TEVA PFE SNY LLY ABBV AZN CRCT SPRO CRNX

Par Health Names Norv McAndrew as EVP, Chief Legal Officer and Corporate Secretary

prnewswire.com
TEVA JNJ PFE PRPH